Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CG Oncology Inc. Common stock
CGON | US
68.68
USD-1.21
-1.73%
CGON | US
Loading StockChartView...
About CG Oncology Inc. Common stock
Sector
US
Industry
US
Earnings date
30/06/2024
As of date
24/04/2026
Close
68.68
Open
69.86
High
70.00
Low
68.16
View Less
CGON | US
Risk
51.4
Sharpe
3.40
Luna's Score
63/100
Recommendation
Hold
Luna says (CGON | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
High Short-term Volatility
Midcap (2B - 10B USD)
Weak Operating Margin (< 10%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
61.9%1 month
51.4%3 months
47.1%6 months
63.4%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.22
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
-
Ent. to rev.
3.40K
PEG
-
Other Fundamentals
EBITDA
-68.18M
MarketCap
4.52B
MarketCap(USD)
4.52B
Div. yield
-
Op. margin
-4.25K
Erngs. growth
-
Rev. growth
172.70
Ret. on equity
-
Short ratio
4.11
Short perc.
4.27
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
10.53
Range1M
10.53
Range3M
25.05
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.43
Price X volume
33.01M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | - | - |
| Ent. to Revenue | 3,400.63 | - | - |
| PE Ratio | - | - | - |
| Price to Book | 4.22 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 47.12 | - | - |
| Debt to Equity | 0.00 | - | - |
| Debt to Assets | 0.00 | - | - |
| Market Cap | 4.52B | - | - |
